Authors:
VIROONCHATAPAN E
SATO H
UENO M
ADACHI I
MURATA J
SAIKI I
TAZAWA K
HORIKOSHI I
Citation: E. Viroonchatapan et al., MICRODIALYSIS ASSESSMENT OF 5-FLUOROURACIL RELEASE FROM THERMOSENSITIVE MAGNETOLIPOSOMES INDUCED BY AN ELECTROMAGNETIC-FIELD IN TUMOR-BEARING MICE, Journal of drug targeting, 5(5), 1998, pp. 379-390
Authors:
KITAZAWA H
SATO H
ADACHI I
MASUKO Y
HORIKOSHI I
Citation: H. Kitazawa et al., MICRODIALYSIS ASSESSMENT OF FIBRIN GLUE CONTAINING SODIUM ALGINATE FOR LOCAL-DELIVERY OF DOXORUBICIN IN TUMOR-BEARING RATS, Biological & pharmaceutical bulletin, 20(3), 1997, pp. 278-281
Authors:
ZHENG NX
SATO H
KOBAYASHI F
MASUKO Y
ADACHI I
HORIKOSHI I
Citation: Nx. Zheng et al., RECTAL ABSORPTION OF OZAGREL FROM A SUPPOSITORY CONTAINING ITS COMMERCIAL TABLET IN HEALTHY-HUMAN SUBJECTS, Biological & pharmaceutical bulletin, 20(3), 1997, pp. 282-284
Authors:
ZHAO FQ
ZHENG NX
SATO H
ADACHI I
HORIKOSHI I
Citation: Fq. Zhao et al., PHARMACOKINETICS OF A CHINESE TRADITIONAL MEDICINE, DANSHENSU (3,4-DIHYDROXYPHENYLLACTIC ACID), IN RABBITS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Biological & pharmaceutical bulletin, 20(3), 1997, pp. 285-287
Citation: Ym. Wang et al., IN-VITRO AND IN-VIVO EVALUATION OF TAXOL RELEASE FROM POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES CONTAINING ISOPROPYL MYRISTATE AND DEGRADATION OF THE MICROSPHERES, Journal of controlled release, 49(2-3), 1997, pp. 157-166
Authors:
VIROONCHATAPAN E
SATO H
UENO M
ADACHI I
TAZAWA K
HORIKOSHI I
Citation: E. Viroonchatapan et al., RELEASE OF 5-FLUOROURACIL FROM THERMOSENSITIVE MAGNETOLIPOSOMES INDUCED BY AN ELECTROMAGNETIC-FIELD, Journal of controlled release, 46(3), 1997, pp. 263-271
Citation: H. Sato et al., PHARMACOKINETIC STUDY OF TAXOL-LOADED POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES CONTAINING ISOPROPYL MYRISTATE AFTER TARGETED DELIVERY TO THE LUNG IN MICE, Biological & pharmaceutical bulletin, 19(12), 1996, pp. 1596-1601
Citation: H. Sato et al., MICRODIALYSIS ASSESSMENT OF MICROFIBROUS COLLAGEN CONTAINING A P-GLYCOPROTEIN-MEDIATED TRANSPORT INHIBITOR, CYCLOSPORINE-A, FOR LOCAL-DELIVERY OF ETOPOSIDE, Pharmaceutical research, 13(10), 1996, pp. 1565-1569
Citation: Nx. Zheng et al., PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF DP-1904, A NOVEL THROMBOXANE SYNTHETASE INHIBITOR IN RABBITS, BASED ON AN INDIRECT RESPONSE MODEL, European journal of drug metabolism and pharmacokinetics, 21(4), 1996, pp. 285-293
Citation: H. Sato et al., IMPORTANCE OF RECEPTOR-MEDIATED ENDOCYTOSIS IN PEPTIDE DELIVERY AND TARGETING - KINETIC ASPECTS, Advanced drug delivery reviews, 19(3), 1996, pp. 445-467
Citation: H. Sato et al., ADD-IN MACROS FOR RAPID AND VERSATILE CALCULATION OF NON-COMPARTMENTAL PHARMACOKINETIC PARAMETERS ON MICROSOFT-EXCEL SPREADSHEETS, Computer methods and programs in biomedicine, 50(1), 1996, pp. 43-52
Citation: H. Sato et al., IMPLEMENTATION OF A REFERENCE MANAGEMENT-SYSTEM, MACREFER, UNDER HYPERCARD, Computer methods and programs in biomedicine, 50(1), 1996, pp. 53-61
Authors:
VIROONCHATAPAN E
SATO H
UENO M
ADACHI I
TAZAWA K
HORIKOSHI I
Citation: E. Viroonchatapan et al., MAGNETIC TARGETING OF THERMOSENSITIVE MAGNETOLIPOSOMES TO MOUSE LIVERS IN AN IN-SITU ONLINE PERFUSION SYSTEM, Life sciences, 58(24), 1996, pp. 2251-2261
Citation: Ym. Wang et al., OPTIMIZATION OF THE FORMULATION DESIGN OF CHITOSAN MICROSPHERES CONTAINING CISPLATIN, Journal of pharmaceutical sciences, 85(11), 1996, pp. 1204-1210
Citation: Ym. Wang et al., PREPARATION AND CHARACTERIZATION OF POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES FOR TARGETED DELIVERY OF A NOVEL ANTICANCER AGENT, TAXOL, Chemical and Pharmaceutical Bulletin, 44(10), 1996, pp. 1935-1940
Citation: A. Ono et al., STUDY ON HEPATIC-ARTERY CHEMOEMBOLIZATION USING TEMPERATURE-SENSITIVELIPOSOME OR LIPIODOL EMULSION, Biological & pharmaceutical bulletin, 18(2), 1995, pp. 279-283
Authors:
MIMURA Y
KOBAYASHI S
OKABE M
KIMURA I
HORIKOSHI I
KIMURA M
Citation: Y. Mimura et al., ANTI-COMPETENCE EFFECTS OF SYNTHETIC PHTHALIDE DERIVATIVES ON PLATELET-DERIVED GROWTH FACTOR-INDUCED DNA-SYNTHESIS IN PRIMARY CULTURES OF RAT AORTA SMOOTH-MUSCLE CELLS, Biological & pharmaceutical bulletin, 18(12), 1995, pp. 1660-1664
Authors:
ZHENG NX
SATO H
ADACHI I
KANAMOTO I
HORIKOSHI I
Citation: Nx. Zheng et al., PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES OF A THROMBOXANE SYNTHETASE INHIBITOR, OZAGREL, IN RABBITS, Biological & pharmaceutical bulletin, 18(12), 1995, pp. 1738-1743
Authors:
MASUKO Y
TAZAWA K
VIROONCHATAPAN E
TAKEMORI S
SHIMIZU T
FUJIMAKI M
NAGAE H
SATO H
HORIKOSHI I
Citation: Y. Masuko et al., POSSIBILITY OF THERMOSENSITIVE MAGNETOLIPOSOMES AS A NEW AGENT FOR ELECTROMAGNETIC INDUCED HYPERTHERMIA, Biological & pharmaceutical bulletin, 18(12), 1995, pp. 1802-1804
Authors:
MIMURA Y
KOBAYASHI S
NOTOYA K
OKABE M
KIMURA I
HORIKOSHI I
KIMURA M
Citation: Y. Mimura et al., ACTIVATION BY ALPHA(1)-ADRENERGIC AGONISTS OF THE PROGRESSION PHASE IN THE PROLIFERATION OF PRIMARY CULTURES OF SMOOTH-MUSCLE CELLS IN MOUSE AND RAT AORTA, Biological & pharmaceutical bulletin, 18(10), 1995, pp. 1373-1376
Authors:
VIROONCHATAPAN E
UENO M
SATO H
ADACHI I
NAGAI H
TAZAWA K
HORIKOSHI I
Citation: E. Viroonchatapan et al., PREPARATION AND CHARACTERIZATION OF DEXTRAN MAGNETITE-INCORPORATED THERMOSENSITIVE LIPOSOMES - AN ONLINE FLOW SYSTEM FOR QUANTIFYING MAGNETIC RESPONSIVENESS, Pharmaceutical research, 12(8), 1995, pp. 1176-1183
Citation: Hx. Liu et al., MECHANISM OF PROMOTION OF LYMPHATIC DRUG ABSORPTION BY MILK-FAT GLOBULE-MEMBRANE, International journal of pharmaceutics, 118(1), 1995, pp. 55-64
Authors:
SATO H
LIU HX
ADACHI I
UENO M
LEMAIRE M
HORIKOSHI I
Citation: H. Sato et al., ENHANCEMENT OF THE INTESTINAL-ABSORPTION OF A CYCLOSPORINE DERIVATIVEBY MILK-FAT GLOBULE-MEMBRANE, Biological & pharmaceutical bulletin, 17(11), 1994, pp. 1526-1528
Authors:
ONO A
YAMAGUCHI M
HORIKOSHI I
SHINTANI T
UENO M
Citation: A. Ono et al., CALCEIN RELEASE FROM TEMPERATURE-SENSITIVE LIPOSOME WITH OR WITHOUT STIRRING, Biological & pharmaceutical bulletin, 17(1), 1994, pp. 166-168
Authors:
SASAYAMA S
ASANOI H
KIHARA Y
YOKAWA S
TERADA Y
YOSHIDA S
EJIRI M
HORIKOSHI I
Citation: S. Sasayama et al., CLINICAL EFFECTS OF LONG-TERM ADMINISTRATION OF PIMOBENDAN IN PATIENTS WITH MODERATE CONGESTIVE-HEART-FAILURE, Heart and vessels, 9(3), 1994, pp. 113-120